Sorrento Therapeutics's market cap is currently ―. The company's EPS TTM is $-1.056; its P/E ratio is -0.02; Sorrento Therapeutics is scheduled to report earnings on August 10, 2023, and the estimated EPS forecast is $―. See an overview of income statement, balance sheet, and cash flow financials.

	Jun 23	Mar 23	Dec 22	Sep 22	Jun 22
Income Statement	-
Total Revenue	$ 12.61M	$ 10.60M	$ 15.59M	$ 17.40M	$ 11.46M
Gross Profit	$ 15.03M	$ -8.99M	$ -5.42M	$ 9.13M	$ 5.76M
EBIT	$ -105.20M	$ -141.66M	$ -210.98M	$ -90.91M	$ -218.28M
EBITDA	$ -99.48M	$ -136.73M	$ -209.85M	$ -87.55M	$ -215.05M
Net Income Common Stockholders	$ -95.21M	$ -139.62M	$ -223.69M	$ -89.58M	$ -218.76M
Balance Sheet	-
Cash, Cash Equivalents and Short-Term Investments	$ 80.64M	$ 50.32M	$ 49.98M	$ 117.86M	$ 133.60M
Total Assets	$ 456.77M	$ 460.06M	$ 472.84M	$ 615.61M	$ 632.13M
Total Debt	$ 207.60M	$ 169.55M	$ 134.50M	$ 168.21M	$ 204.61M
Net Debt	$ 126.97M	$ 119.23M	$ 84.53M	$ 50.35M	$ 71.00M
Total Liabilities	$ 654.65M	$ 587.48M	$ 494.51M	$ 485.41M	$ 496.37M
Stockholders Equity	$ -205.11M	$ -125.50M	$ -18.61M	$ 131.85M	$ 132.02M
Cash Flow	-
Free Cash Flow	$ -55.80M	$ -49.55M	$ -72.86M	$ -65.01M	$ -83.69M
Operating Cash Flow	$ -55.66M	$ -49.46M	$ -68.34M	$ -61.17M	$ -80.99M
Investing Cash Flow	$ -140.00K	$ 1.68M	$ -5.03M	$ -8.09M	$ -1.73M
Financing Cash Flow	$ 88.81M	$ 61.20M	$ 25.08M	$ 71.50M	$ 41.77M

Currency in USD

Sorrento Therapeutics Earnings and Revenue History

Income Statement >

Sorrento Therapeutics Debt to Assets

Balance Sheet >

Sorrento Therapeutics Cash Flow

Cash Flow >

Sorrento Therapeutics Forecast EPS vs Actual EPS

Earnings >

Get More with TipRanks Premium

What's Included in PREMIUM?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing